BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26391425)

  • 1. Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series.
    Patra S
    Curr Drug Saf; 2016; 11(1):102-3. PubMed ID: 26391425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tardive dyskinesia in a child treated with atypical antipsychotics].
    Wittevrongel E; Vranken E; Pepermans A; Jaspers T
    Tijdschr Psychiatr; 2020; 62(10):901-905. PubMed ID: 33184822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covert dyskinesia associated with aripiprazole: a case report and review of the literature.
    Moseley CN; Simpson-Khanna HA; Catalano G; Catalano MC
    Clin Neuropharmacol; 2013; 36(4):128-30. PubMed ID: 23860346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole-induced tardive dyskinesia in patients with schizophrenia: A case report of twins.
    She S; Kuang Q; Zheng Y
    Schizophr Res; 2018 Jul; 197():564-565. PubMed ID: 29128325
    [No Abstract]   [Full Text] [Related]  

  • 5. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 4: Case Report Data.
    Macaluso M; Flynn A; Preskorn S
    J Psychiatr Pract; 2016 May; 22(3):203-20. PubMed ID: 27123800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data.
    Preskorn SH; Macaluso M
    J Psychiatr Pract; 2016 Mar; 22(2):117-23. PubMed ID: 27138080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
    Selfani K; Soland VL; Chouinard S; Huot P
    Neurologist; 2017 Jan; 22(1):24-28. PubMed ID: 28009769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
    Vijayakumar D; Jankovic J
    Drugs; 2016 May; 76(7):779-87. PubMed ID: 27091214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 2: Preclinical and Early Phase Human Proof of Concept Studies.
    Macaluso M; Flynn A; Preskorn S
    J Psychiatr Pract; 2016 Jan; 22(1):42-9. PubMed ID: 26813487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder: Part 1.
    Preskorn S; Flynn A; Macaluso M
    J Psychiatr Pract; 2015 Sep; 21(5):359-69. PubMed ID: 26348804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covert Dyskinesia With Aripiprazole: A Case Report.
    Mahgoub Y; Hameed A; Francis A
    Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27722028
    [No Abstract]   [Full Text] [Related]  

  • 13. Covert Dyskinesia With Aripiprazole: Tip of the Iceberg? A Case Report and Literature Review.
    Gomaa H; Mahgoub Y; Francis A
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):67-70. PubMed ID: 33347026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
    Miller DD; Eudicone JM; Pikalov A; Kim E
    J Clin Psychiatry; 2007 Dec; 68(12):1901-6. PubMed ID: 18162021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of irreversible aripiprazole-induced tardive dystonia with clozapine: a case report.
    Joe S; Park J; Lim J; Park C; Ahn J
    BMC Psychiatry; 2015 Oct; 15():253. PubMed ID: 26482558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: a 24-week follow-up study.
    Chan CH; Chan HY; Chen YC
    Int Clin Psychopharmacol; 2018 May; 33(3):155-162. PubMed ID: 29324468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
    Villeneuve A; Lajeunesse C
    Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing antipsychotic-induced tardive dyskinesia.
    Gardos G
    Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
    Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
    J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole-induced improvement in tardive dyskinesia.
    Duggal HS
    Can J Psychiatry; 2003 Dec; 48(11):771-2. PubMed ID: 14733461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.